Physician profile
Olivia Zaczyk
NPI 1477254639
$4,001.99
in general payments reported to CMS, 2019-2025
21 companies · $1,861 in 2025
The $1,861 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $887 · 2024: $1,254 · 2025: $1,861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,718 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,718.16 |
| Education | $283.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $784.46 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $676.14 | 2023-2025 | |
| Incyte Corporation | $443.73 | 2023-2025 | Opzelura |
| Lilly USA, LLC | $343.78 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $200.78 | 2023-2025 | Ilumya |
| Ucb, INC. | $190.84 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $185.15 | 2023-2025 | Dupixent |
| Janssen Biotech, INC. | $179.93 | 2024-2025 | Tremfya |
| Dermavant Sciences, INC. | $129.98 | 2023-2024 | Vtama |
| Pfizer INC. | $110.41 | 2023-2025 | |
| Amgen INC. | $106.86 | 2023-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $101.22 | 2023-2024 | Sotyktu |
| Sanofi-Aventis U.S. LLC | $99.99 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.01 | 2025 | Spevigo |
| Arcutis Biotherapeutics, INC. | $86.12 | 2024-2025 | Zoryve |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $83.00 | 2025 | |
| Leo Pharma INC. | $57.67 | 2023-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $49.81 | 2024 | Aklief |
| Lnhc, INC | $48.78 | 2025 | Zelsuvmi |
| Organogenesis INC. | $18.65 | 2025 | Novachor |
| Organon LLC | $17.68 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Zaczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.